4/A
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001725092-26-000009
Options or other derivatives
- Chief Executive Officer acquired 136,359 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lin Shao-Lee · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-01 | Grant or award : show line 1 in the form Pre-Funded Warrants (Right to Buy) | +90,906 | $11.00 | $999,966 | 90,906 | I |
| 2026-06-01 | Grant or award : show line 2 in the form Common Stock Warrants (Right to Buy) | +45,453 | 45,453 | I |
Loading xslF345X06/form4a-07302026_080752.xml…